Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRospective Study for the TrEatment of Atherosclerotic Lesions in the Infrapopliteal Arteries Using the Serranator® DevicE: PRELUDE BTK (Below The Knee) Study

NCT03693963 is registered in ClinicalTrials.gov with Cagent Vascular LLC as lead sponsor.

NCT NCT03693963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03693963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRospective Study for the TrEatment of Atherosclerotic Lesions in the Infrapopliteal Arteries Using the Serranator® DevicE: PRELUDE BTK (Below The Knee) Study
Lead sponsor
Cagent Vascular LLC
Phase
Not applicable
Overall status
Completed
Start date
December 17, 2019
Completion date
October 23, 2020
Enrollment
49 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral arterial disease